EUVIMEDEUVIMED entdecken
Crossref

Extraterritorial Patent Infringement: Gene Editing with CRISPR-Cas Perspective

Laura Kohli

Arizona Law Journal of Emerging Technologies · 2021

DOI: 10.2458/azlawjet.5507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arizona Law Journal of Emerging Technologies, 2021. Verfasst von Laura Kohli.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advent of CRISPR, with all its extraordinary potential, has exposed some seams and uncertainties in how U.S. patent law operates extraterritorially. The CRISPR-Cas system can be used to edit the human genome to correct diseases by way of a gRNA that guides a Cas enzyme to a certain DNA sequence location to make a corrective edit. Despite the presumption against extraterritorial patent protection, if an actor exports a component created in the U.S. that, when combined with other components abroad, will infringe a patented invention, the actor can be liable for infringement under 35 U.S.C. § 271(f). By way of an example, consider a patented invention that relates to a Cas9 protein and a DNA-targeting RNA with specific features (gRNA) to produce a modification of the targeted DNA molecule. If a party supplies a library of specific gRNAs for export to be combined with CRISPR-Cas9 in order to practice a patented invention as a whole, there may be 271(f) liability. Notably, the crux of the puzzle rests on the analysis of what a “component” is in such gene editing inventions. Courts could view Cas effector-encoding amino acid sequences, Cas protein domains, Cas effectors themselves, gRNA-encoding nucleotide sequences, exons, or gRNA molecules themselves as components. In this writing, I propose that sequences that encode the Cas effector proteins and the gRNAs be considered components for 271(f) liability purposes.

Zitieren

APA

Kohli, L. (2021). Extraterritorial Patent Infringement: Gene Editing with CRISPR-Cas Perspective. Arizona Law Journal of Emerging Technologies. https://doi.org/10.2458/azlawjet.5507

Vancouver

Kohli L. Extraterritorial Patent Infringement: Gene Editing with CRISPR-Cas Perspective. Arizona Law Journal of Emerging Technologies. 2021. doi:10.2458/azlawjet.5507

BibTeX
@article{Kohli2021,
  author = {Kohli, Laura},
  title = {Extraterritorial Patent Infringement: Gene Editing with CRISPR-Cas Perspective},
  journal = {Arizona Law Journal of Emerging Technologies},
  year = {2021},
  doi = {10.2458/azlawjet.5507}
}
Kostenlos starten →